Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Medicinal Chemistry and Bioinformatics Centre, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Adv Protein Chem Struct Biol. 2021;124:87-119. doi: 10.1016/bs.apcsb.2020.09.005. Epub 2021 Feb 13.
Protein kinases use ATP to phosphorylate other proteins. Phosphorylation (p) universally orchestrates a fine-tuned network modulating a multitude of biological processes. Moreover, the start of networks, ATP-binding site, has been recognized dual roles to impact protein kinases function: (i) orthosteric inhibition, via being blocked to interference ATP occupying and (ii) allosteric regulation, via being altered first to induce further conformational changes. The above two terminologies are widely used in drug design, which has acquired quite a significant progress in the protein kinases field over the past 2 decades. Most small molecular inhibitors directly compete with ATP to implement orthosteric inhibition, still exhibiting irreplaceable and promising therapeutic effects. Additionally, numerous inhibitors can paradoxically lead protein kinases to hyperphosphorylation, even activation, indicative of the allosteric regulation role of the ATP-binding site. Here, we review the quintessential examples that apply for the dual roles in diverse ways. Our work provides an insight into the molecular mechanisms under the dual roles and will be promisingly instructive for future drug development.
蛋白激酶利用 ATP 将其他蛋白质磷酸化。磷酸化(p)普遍协调微调网络,调节多种生物过程。此外,网络的起点,ATP 结合位点,已被认为具有双重作用来影响蛋白激酶的功能:(i)变构抑制,通过被阻止干扰 ATP 的占据和(ii)变构调节,通过首先改变来诱导进一步的构象变化。这两个术语在药物设计中被广泛使用,在过去的 20 年中,在蛋白激酶领域取得了相当大的进展。大多数小分子抑制剂直接与 ATP 竞争以实现变构抑制,仍然表现出不可替代和有前途的治疗效果。此外,许多抑制剂可以使蛋白激酶反常地发生过度磷酸化,甚至激活,表明 ATP 结合位点具有变构调节作用。在这里,我们回顾了以不同方式适用于双重作用的典型例子。我们的工作提供了对双重作用下分子机制的深入了解,有望为未来的药物开发提供有价值的指导。